AI assistant
Sending…
Aurinia Pharmaceuticals Inc. — Director's Dealing 2021
May 13, 2021
31941_dirs_2021-05-13_9fd8f1d8-67f3-4209-9c91-f37f11258f8e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aurinia Pharmaceuticals Inc. (AUPH)
CIK: 0001600620
Period of Report: 2021-05-11
Reporting Person: MacKay-Dunn R. Hector (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-11 | Common Stock | P | 500 | $11.17 | Acquired | 2000 | Direct |
| 2021-05-11 | Common Stock | P | 1000 | $11.14 | Acquired | 3000 | Direct |
| 2021-05-12 | Common Stock | P | 1400 | $11.26 | Acquired | 4400 | Direct |
| 2021-05-12 | Common Stock | P | 1600 | $11.275 | Acquired | 6000 | Direct |
More from Aurinia Pharmaceuticals Inc.
Regulatory Filings
2026
May 11
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3